Modulating the gut microbiome with dietary interventions to reduce cardiometabolic disease risk

Affiliations

¹ Department of Cardiovascular and Pulmonary Science, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.

Comment

Giovanna Liuzzo et al. Eur Heart J. 2021.

. 2021 Jun 7;42(22):2152-2153.

doi: 10.1093/eurheartj/ehab261.

¹ Department of Cardiovascular and Pulmonary Science, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.

No abstract available

Comment on

The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk.
Wang DD, Nguyen LH, Li Y, Yan Y, Ma W, Rinott E, Ivey KL, Shai I, Willett WC, Hu FB, Rimm EB, Stampfer MJ, Chan AT, Huttenhower C. Wang DD, et al. Nat Med. 2021 Feb;27(2):333-343. doi: 10.1038/s41591-020-01223-3. Epub 2021 Feb 11. Nat Med. 2021. PMID: 33574608 Free PMC article.

The Effects of Moderate Alcohol Consumption on Circulating Metabolites and Gut Microbiota in Patients With Coronary Artery Disease.
Zhao X, Zhou R, Li H, Fan Y, Sun Y, Hu X, Zhang S. Zhao X, et al. Front Cardiovasc Med. 2021 Nov 2;8:767692. doi: 10.3389/fcvm.2021.767692. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34796220 Free PMC article.
Colon specific delivery of miR-155 inhibitor alleviates estrogen deficiency related phenotype via microbiota remodeling.
Zhao L, Zhou T, Chen J, Cai W, Shi R, Duan Y, Yuan L, Xing C. Zhao L, et al. Drug Deliv. 2022 Dec;29(1):2610-2620. doi: 10.1080/10717544.2022.2108163. Drug Deliv. 2022. PMID: 35938574 Free PMC article.